Related Experiment Video
Updated: Feb 5, 2026

Imaging the Human Immunological Synapse
Published on: December 26, 2019
Immunological effects of BRAF+MEK inhibition
Paolo A Ascierto1, Reinhard Dummer2
1Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione "G. Pascale", Napoli, Italy.
Abstract:
Recent developments in immunotherapy have prolonged overall survival in metastatic melanoma with the possibility to reach a long-term benefit. Targeted therapies based on BRAF and MEK inhibition also seem to have a long-term beneficial effect, which is more evident in patients with favorable baseline characteristics, namely normal levels of lactate dehydrogenase, without brain metastases, and low tumor burden. This long-term benefit of targeted therapies might be related to an immune-modulation: indeed BRAF and MEK inhibitors affect tumor microenvironment and immune surveillance, and it has been shown that patients with complete response to targeted treatment have a pre-existing favorable immunologic signature.
More Related Videos
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Feedback Inhibition
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Enzyme Inhibition
Inhibition of Cdk Activity
Framing Effects

